With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise.
The biotech sector, represented by the XBI ETF, is trading higher today, influenced by a general market upswing ahead of key inflation data and major tech earnings. This broad-based optimism is providing a tailwind for the sector. This move also builds on strong, recent momentum within the biotechnology industry, following a major breakthrough announcement last week from Moderna and Merck regarding a successful late-stage trial for their personalized mRNA cancer vaccine, which has significantly boosted investor confidence in the sector.